Physician profile
Frantz Paul
NPI 1467770743
$671.68
in general payments reported to CMS, 2019-2025
16 companies · $259 in 2025
The $259 reported for 2025 was more than what 92% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $63.43 · 2022: $36.33 · 2023: $62.67 · 2024: $250 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $571.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $181.87 | 2023-2025 | Entyvio, Eohilia |
| Vertos Medical, INC. | $102.84 | 2024 | Mild Device Kit |
| Stimwave Technologies Incorporated | $49.98 | 2021-2022 | |
| Janssen Biotech, INC. | $40.81 | 2025 | Tremfya |
| Biotronik Nro, INC. | $36.62 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.20 | 2023-2024 | Xifaxan, Trulance |
| Qol Medical, LLC | $34.30 | 2024 | Sucraid |
| Depuy Synthes Sales INC. | $29.89 | 2021 | |
| Collegium Pharmaceutical, INC. | $24.96 | 2025 | Belbuca |
| Tersera Therapeutics LLC | $22.84 | 2023 | Prialt |
| Boston Scientific Corporation | $21.70 | 2024 | Intracept |
| Ardelyx, INC. | $20.12 | 2024 | Ibsrela |
| Kci USA, INC. | $19.89 | 2021 | |
| Stryker Corporation | $18.96 | 2024 | Mild Device Kit |
| Nevro Corp. | $16.54 | 2024 | Senza |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $15.16 | 2024 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frantz Paul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.